Synopsis
Synopsis
0
USDMF
0
JDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Clopidogrel
2. Clopidogrel Besilate
3. Clopidogrel Bisulfate
4. Clopidogrel Hydrochloride
5. Clopidogrel Mepha
6. Clopidogrel Napadisilate
7. Clopidogrel Sandoz
8. Clopidogrel, (+)(s)-isomer
9. Clopidogrel-mepha
10. Iscover
11. Pcr 4099
12. Pcr-4099
13. Plavix
14. Sc 25989c
15. Sc 25990c
16. Sr 25989
1. Clopidogrel Besilate
2. 744256-69-7
3. Bl9vgg8bhw
4. Clopidogrel Benzenesulfonic Acid Salt
5. Clopidogrel Benzenesulfonate
6. (s)-methyl-2-(2-chlorophenyl)-2-(6,7-dihydrothieno(3,2-c)pyridin-5(4h)-yl)acetate Methanesulfonate
7. Benzenesulfonic Acid;methyl (2s)-2-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)acetate
8. (s)-methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4h)-yl)acetate Benzenesulfonate
9. Thieno(3,2-c)pyridine-5(4h)-acetic Acid, Alpha-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (alphas)-, Benzenesulfonate (1:1)
10. Thieno[3,2-c]pyridine-5(4h)-acetic Acid, Alpha-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (alphas)-, Benzenesulfonate (1:1)
11. Unii-bl9vgg8bhw
12. Grepid
13. Schembl365641
14. Clopidogrel Acino Pharma
15. Dtxsid30225441
16. Clopidogrel Acino Pharma Gmbh
17. Clopidogrel Besylate [who-dd]
18. Akos026751491
19. Clopidogrel Besilate [ema Epar]
20. Thieno(3,2-c)pyridine-5(4h)-acetic Acid, Alpha-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (alphas)-, Benzenesulfonate
21. Clopidogrel Besilate [ep Monograph]
22. D10824
23. Q27274743
24. Thieno(3,2-c)pyridine-5(4h)-acetic Acid, .alpha.-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (.alpha.s)-, Benzenesulfonate
25. Thieno(3,2-c)pyridine-5(4h)-acetic Acid, .alpha.-(2-chlorophenyl)-6,7-dihydro-, Methyl Ester, (.alpha.s)-, Benzenesulfonate (1:1)
| Molecular Weight | 480.0 g/mol |
|---|---|
| Molecular Formula | C22H22ClNO5S2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 479.0627928 g/mol |
| Monoisotopic Mass | 479.0627928 g/mol |
| Topological Polar Surface Area | 121 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 565 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
Purinergic P2Y Receptor Antagonists
Compounds that bind to and block the stimulation of PURINERGIC P2Y RECEPTORS. Included under this heading are antagonists for specific P2Y receptor subtypes. (See all compounds classified as Purinergic P2Y Receptor Antagonists.)
ABOUT THIS PAGE
60
PharmaCompass offers a list of Clopidogrel Besylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Clopidogrel Besylate manufacturer or Clopidogrel Besylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clopidogrel Besylate manufacturer or Clopidogrel Besylate supplier.
A Clopidogrel besilate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clopidogrel besilate, including repackagers and relabelers. The FDA regulates Clopidogrel besilate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clopidogrel besilate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clopidogrel besilate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Clopidogrel besilate supplier is an individual or a company that provides Clopidogrel besilate active pharmaceutical ingredient (API) or Clopidogrel besilate finished formulations upon request. The Clopidogrel besilate suppliers may include Clopidogrel besilate API manufacturers, exporters, distributors and traders.
click here to find a list of Clopidogrel besilate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clopidogrel besilate Drug Master File in Korea (Clopidogrel besilate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clopidogrel besilate. The MFDS reviews the Clopidogrel besilate KDMF as part of the drug registration process and uses the information provided in the Clopidogrel besilate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clopidogrel besilate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clopidogrel besilate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clopidogrel besilate suppliers with KDMF on PharmaCompass.
A Clopidogrel besilate CEP of the European Pharmacopoeia monograph is often referred to as a Clopidogrel besilate Certificate of Suitability (COS). The purpose of a Clopidogrel besilate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clopidogrel besilate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clopidogrel besilate to their clients by showing that a Clopidogrel besilate CEP has been issued for it. The manufacturer submits a Clopidogrel besilate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clopidogrel besilate CEP holder for the record. Additionally, the data presented in the Clopidogrel besilate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clopidogrel besilate DMF.
A Clopidogrel besilate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clopidogrel besilate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Clopidogrel besilate suppliers with CEP (COS) on PharmaCompass.
A Clopidogrel besilate written confirmation (Clopidogrel besilate WC) is an official document issued by a regulatory agency to a Clopidogrel besilate manufacturer, verifying that the manufacturing facility of a Clopidogrel besilate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clopidogrel besilate APIs or Clopidogrel besilate finished pharmaceutical products to another nation, regulatory agencies frequently require a Clopidogrel besilate WC (written confirmation) as part of the regulatory process.
click here to find a list of Clopidogrel besilate suppliers with Written Confirmation (WC) on PharmaCompass.
Clopidogrel besilate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clopidogrel besilate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Clopidogrel besilate GMP manufacturer or Clopidogrel besilate GMP API supplier for your needs.
A Clopidogrel besilate CoA (Certificate of Analysis) is a formal document that attests to Clopidogrel besilate's compliance with Clopidogrel besilate specifications and serves as a tool for batch-level quality control.
Clopidogrel besilate CoA mostly includes findings from lab analyses of a specific batch. For each Clopidogrel besilate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clopidogrel besilate may be tested according to a variety of international standards, such as European Pharmacopoeia (Clopidogrel besilate EP), Clopidogrel besilate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clopidogrel besilate USP).